Neogen Chemicals Limited has informed the Exchange about in-principle approval granted by the Board for raising of funds through preferential issue of equity shares.

Neogen Chemicals Limited has received in-principle approval from its Board to raise funds through a preferential issue of equity shares. A preferential issue means shares will be allotted to a select group of investors rather than through a public offer or QIP. The current announcement does not specify the amount to be raised, the issue price, or the identity of the proposed allottees. These details are typically shared in a follow-up announcement once terms are finalised. Shareholders should watch for the next disclosure covering pricing, quantum, and the names of allottees.